Mr M S, aged 30. Driver History: Two years epigastric pain before meals, relieved by alkalis. Pain worse for six months, accompanied by vomiting after meals, weight loss of 12 kg and diarrhoea with pale motions. Family history: The patients' brother had died aged 21 from recurrent gastric and duodenal ulceration in association with multiple pancreatic tumours. His mother had died aged 43 following total gastrectomy for peptic ulceration; a pancreatic tumour was discovered at operation. Her brother had suffered from steatorrhoea, and had died from acute mediastinitis following a ruptured cesophagus. The patient's maternal grandfather, and the latter's three brothers, suffered from peptic ulceration. Two other members of the family had hyperparathyroidism. On examination: The only abncrmality was deep epigastric tenderness. Investigations: Plasma calcium (corrected for specific gravity) 12-9-14-0, plasma phosphorus 2-2 mg/100 ml. Alkaline phosphatase 8 K-A units. 24-h urine calcium 115-157, phosphorus 582-840 mg. Fvcal fat excretion 9 5 g/24 h. Pentagastrin test: basal acid secretion 43-2, maximal stimulated secretion 48-0 mEq[H+]/h. Barium meal: gross excess of resting juice. Large duodenal ulcer and dilated duodenal loop containing several fluid levels. Pancreatic arteriogram normal. Plasma gastrin levels greatly elevated: radioimmunoassay 2-5, bioassay 8-15 ng/ml. At laparotomy (Professor C G Clark) multiple pancreatic adenomata were found. The tail of the pancreas, containing several tumours, was excised, and total gastrectomy performed. Histology showed multiple islet cell adenomata. Extracts of the tumour prepared by the method of Gregory & Tracy (1964) contained 110 ng gastrin per gram tumour tissue. Two months later, a parathyroid adenoma and two hyperplastic parathyroid glands were excised (Mr D R Davies). Histology revealed chief cell hyperplasia. Following gastrectomy, plasma gastrin levels remained unchanged, but after parathyroidectomy the plasma gastrin fell towards normal levels. The changes in plasma gastrin mirrored the changes in plasma calcium.
Ten relatives of the patient have so far been traced, and plasma gastrin and calcium levels have been measured. A cousin of the patient has a raiscd plasma gastrin and is suspected of having the Zollinger-Ellison syndrome. Two relatives have hypercalcwmia, one of whom has recently undergone surgery for hyperparathyroidism.
Comment
Our patient had both the Zollinger-Ellison syndrome and hyperparathyroidism. In a similar patient, in whom parathyroidectomy was performed prior to gastrectomy, Trudeau & Mc-Guigan (1969) noted a striking relationship between plasma calcium and gastrin, both levels falling after parathyroidectomy. A similar relationship was found in our patient, supporting the suggestion that plasma calcium levels appear to control tumour release of gastrin to some extent.
We have obtained details so far of 19 of the 37 relatives of our patient, over four generations. They include 4 probable cases of Zollinger-Ellison syndrome, 4 cases of hyperparathyroidism and 4 cases of peptic ulceration. Adenomata of other endocrine glands occur in 20% of patients with Zollinger-Ellison syndrome, and there is a family history of endocrine adenomata in 5% (Ellison & Wilson 1964) . Several families have been reported where both Zollinger-Ellison syndrome and hyperparathyroidism have occurred (Schmid et al. 1961 , Wermer 1963 , Johnson et al. 1967 ) and our patient's family is a further example. The probable mode of inheritance is through a dominant pleiotropic gene with variable expression. Dr Lyal Watson (University College Hospital, London WC1) said that among the first 300 patients with primary and tertiary hyperparathyroidism successfully diagnosed and treated at University College Hospital by the removal of parathyroid tumours, there had been 8 patients in five families with the polyglandular syndrome. There had also been 3 patients in one family with familial hyperparathyroidism alone. There was a strong presumption of tertiary hyperparathyroidism in these 11 cases, the causal factor being unknown but clearly hereditary in origin (Davies D R, Dent C E & Watson L, 1968, Brit. med. J. iii, 395).
There might be two different polyglandular syndromes. In the better known variety tumours of the parathyroid glands were associated with disorders of the pituitary and pancreas. Steiner et al. (1968) had suggested that a syndrome characterized by the occurrence of parathyroid tumours with pheochromocytoma, medullary thyroid carcinoma and more rarely with Cushing's syndrome appeared to be genetically distinct from the other polyglandular syndrome. The name 'multiple endocrine neoplasia Type II' had been suggested for the more newly described entity (Steiner A L, Goodman A D & Powers S R, 1968, Medicine (Baltimore) 47, 371).
